18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617

by Giesel, Frederik L., Cardinale, Jens, Schäfer, Martin, Neels, Oliver, Benešová, Martina, Mier, Walter, Haberkorn, Uwe, Kopka, Klaus, Kratochwil, Clemens
Published 2016

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

by Afshar-Oromieh, Ali, Zechmann, Christian M., Malcher, Anna, Eder, Matthias, Eisenhut, Michael, Linhart, Heinz G., Holland-Letz, Tim, Hadaschik, Boris A., Giesel, Frederik L., Debus, Jürgen, Haberkorn, Uwe
Published 2013

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

by Giesel, Frederik L., Fiedler, H., Stefanova, M., Sterzing, F., Rius, M., Kopka, K., Moltz, J. H., Afshar-Oromieh, A., Choyke, P. L., Haberkorn, U., Kratochwil, C.
Published 2015

68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients

by Sterzing, Florian, Kratochwil, Clemens, Fiedler, Hannah, Katayama, Sonja, Habl, Gregor, Kopka, Klaus, Afshar-Oromieh, Ali, Debus, Jürgen, Haberkorn, Uwe, Giesel, Frederik L.
Published 2015

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

by Afshar-Oromieh, Ali, Avtzi, Eleni, Giesel, Frederik L., Holland-Letz, Tim, Linhart, Heinz G., Eder, Matthias, Eisenhut, Michael, Boxler, Silvan, Hadaschik, Boris A., Kratochwil, Clemens, Weichert, Wilko, Kopka, Klaus, Debus, Jürgen, Haberkorn, Uwe
Published 2014